Intelligence · Clinical Development
Pipeline search results
Programs matching “Astra” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 467 pipeline programs matching "Astra" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Olaparib 300mg tablets
AstraZeneca
Newly Diagnosed
1 trial -
Olaparib 300mg tablets
AstraZeneca
Relapsed Ovarian Cancer
1 trial -
Osimertinib
AstraZeneca
Cancer
1 trial -
PACIFIC2/D933KC00001
AstraZeneca AB
Patients with Locally Advanced, Unresectable Non-small Cell Lung Cancer (Stage III)
1 trial -
PBP-301
Lacuna Pharma Pty Ltd
Metastatic castration-resistant prostate cancer (mCRPC)
1 trial -
PROpel D081SC00001
AstraZeneca AB
Metastatic castration-resistant prostate cancer
1 trial -
Placebo
AstraZeneca
Irritable Bowel Syndrome With Constipation (IBS-C)
1 trial -
Puxitatug Samrotecan
AstraZeneca
Endometrial Cancer
1 trial -
Quetiapine SR
AstraZeneca
Major Depressive Disorder
1 trial -
Rilvegostomig
AstraZeneca
Non-small Cell Lung Cancer
1 trial -
Roflumilast
AstraZeneca
COPD
1 trial -
Roflumilast
AstraZeneca
Asthma
1 trial -
Rosuvastatin 20mg
AstraZeneca
Homozygous Familial Hypercholesterolemia (HoFH)
1 trial -
Roxadustat
AstraZeneca
Anemia
1 trial -
SHR3162-III-305
Lacuna Pharma Pty Ltd
Metastatic Castration-Resistant Prostate Cancer
1 trial -
SOLO 1-D0818C00001
AstraZeneca AB
BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer
1 trial -
Savolitinib
AstraZeneca
Carcinoma
1 trial -
Saxagliptin
AstraZeneca
Diabetes
1 trial -
Seroquel Sustained Release (SR)
AstraZeneca
Schizophrenic Disorder
1 trial -
Sodium Zirconium Cyclosilicate (SZC)
AstraZeneca
Hyperkalemia
1 trial -
Suprefact Depot 9 for low-volume metastatic castration-sensitive prostate cancer
Disc Medicine
low-volume metastatic castration-sensitive prostate cancer
1 trial -
Surovatamig
AstraZeneca
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV
1 trial -
Symbicort Turbuhaler
AstraZeneca
Asthma
1 trial -
Tesaglitazar
AstraZeneca
Type 2 Diabetes
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.